N-cyclobutylmethyl-6,14-endoethano-7α-(1-(R)-hydroxy-1-cyclopropyl-ethyl)-tetrahydronorthebaine | 900518-02-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 菲及其衍生物
• 英文名称: N-cyclobutylmethyl-6,14-endoethano-7α-(1-(R)-hydroxy-1-cyclopropyl-ethyl)-tetrahydronorthebaine
• CAS: 900518-02-7
• 化学式: C₃₀H₄₁NO₄
• 分子量: 479.66
• InChiKey: ZSXANMGIGXFXBD-XELDOGJXSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.47
• 重原子数：
  35.0
• 可旋转键数：
  6.0
• 环数：
  9.0
• sp3杂化的碳原子比例：
  0.8
• 拓扑面积：
  51.16
• 氢给体数：
  1.0
• 氢受体数：
  5.0

反应信息

• 作为反应物：
  描述：

  N-cyclobutylmethyl-6,14-endoethano-7α-(1-(R)-hydroxy-1-cyclopropyl-ethyl)-tetrahydronorthebaine 在 氢氧化钾 作用下， 以 二乙二醇 为溶剂， 反应 2.0h， 以68%的产率得到N-cyclobutylmethyl-6,14-endoethano-7α-(1-(R)-hydroxy-1-cyclopropyl-ethyl)-tetrahydronororipavine
  参考文献：
  名称：

  A highly selective κ-opioid receptor agonist with low addictive potential and dependence liability

  摘要：

  Buprenorphine analogs have been synthesized. In the studies of analgesic and addictive effects in mice and [S-35]GTP gamma S binding assay in human brain tissue, an analog of buprenorphine where the tert-butyl is replaced by a cyclobutyl moiety (16) has been identified as a selective K-partial agonist which gives antinociceptive effects, but has low abuse potential. The results may lead to lower degrees of dysphoria than full K-agonists. (c) 2006 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2006.02.017
• 作为产物：
  描述：

  6,14-endoethano-7α-(1-(R)-hydroxy-1-cyclopropyl-ethyl)-tetrahydrothebaine 在 氢氧化钾 、 magnesium acetate 作用下， 以 二氯甲烷 、 N,N-二甲基甲酰胺 、 二乙二醇 为溶剂， 反应 11.5h， 生成 N-cyclobutylmethyl-6,14-endoethano-7α-(1-(R)-hydroxy-1-cyclopropyl-ethyl)-tetrahydronorthebaine
  参考文献：
  名称：

  A highly selective κ-opioid receptor agonist with low addictive potential and dependence liability

  摘要：

  Buprenorphine analogs have been synthesized. In the studies of analgesic and addictive effects in mice and [S-35]GTP gamma S binding assay in human brain tissue, an analog of buprenorphine where the tert-butyl is replaced by a cyclobutyl moiety (16) has been identified as a selective K-partial agonist which gives antinociceptive effects, but has low abuse potential. The results may lead to lower degrees of dysphoria than full K-agonists. (c) 2006 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2006.02.017